Timing is important in medication administration: A timely review of chronotherapy research

International Journal of Clinical Pharmacy

Volumn 35, Issue 3, 2013, Pages 344-358

  Kaur, Gagandeep ^a   Phillips, Craig ^b   Wong, Keith ^b   Saini, Bandana ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WOOLCOCK INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Chronoeffectiveness; Chronomodulation; Chronopharmacodynamics; Chronopharmacokinetics; Chronotherapy; Drug therapy

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; AMLODIPINE BESYLATE; AMLODIPINE PLUS OLMESARTAN; AMLODIPINE PLUS VALSARTAN; BIMATOPROST PLUS TIMOLOL; EZETIMIBE PLUS SIMVASTATIN; FOSINOPRIL; HYDROCHLOROTHIAZIDE; INDACATEROL; LATANOPROST PLUS TIMOLOL; LEVOTHYROXINE; METHOTREXATE; METHYLPREDNISOLONE; NEBICAPONE; NIFEDIPINE; OLMESARTAN; PERINDOPRIL; PLACEBO; PREDNISONE; RAMIPRIL; SALMETEROL; SIMVASTATIN; SPIRAPRIL; TORASEMIDE; TRANDOLAPRIL PLUS VERAPAMIL; UNINDEXED DRUG; VALSARTAN; VERAPAMIL; VILDAGLIPTIN;

BEDTIME DOSAGE; BIOLOGICAL RHYTHM; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONOBIOLOGY; CHRONOEFFECTIVENESS; CHRONOMODULATION; CHRONOPHARMACODYNAMICS; CHRONOPHARMACOKINETICS; CHRONOPHARMACOLOGY; CHRONOPHYSIOLOGY; CHRONOTHERAPY; CHRONOTOXICOLOGY; CIRCADIAN RHYTHM; CLINICAL EFFECTIVENESS; DISEASE CONTROL; DOSAGE SCHEDULE COMPARISON; DRUG DELIVERY SYSTEM; DRUG DOSE REDUCTION; DRUG UTILIZATION; DYSLIPIDEMIA; EDEMA; EVENING DOSAGE; EVIDENCE BASED PRACTICE; GLAUCOMA; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPOTHYROIDISM; INTRAOCULAR HYPERTENSION; MEDICAL PRACTICE; MEDICATION THERAPY MANAGEMENT; MORNING DOSAGE; MULTIPLE SCLEROSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OPEN ANGLE GLAUCOMA; PATIENT COUNSELING; PRIORITY JOURNAL; PUBLICATION; RESPIRATORY TRACT DISEASE; REVIEW; RHEUMATOID ARTHRITIS;

DRUG CHRONOTHERAPY; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HUMANS; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; TIME FACTORS;

EID: 84878326836     PISSN: 22107703     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-013-9749-0     Document Type: Review

References (76)

1. Lemmer B, Labrecque G. Chronopharmacology and chronotherapeutics: definitions and concepts. Chronobiol Int. 1987;4(3):319-29.
2. Smolensky MH. Chronobiology and chronotherapeutics. Applications to cardiovascular medicine. Am J Hypertens. 1996;9(4 Pt 3):11S-21S.
3. Lemmer B. Relevance for chronopharmacology in practical medicine. Semin Perinatol. 2000;24(4):280-90.
4. Touitou Y, Haus E. Biologic rhythms in clinical and laboratory medicine. Special ed. Berlin: Springer; 1994.
5. Lemmer B. The clinical relevance of chronopharmacology in therapeutics. Pharmacol Res. 1996;33(2):107-15.
6. Sobrino J, Casanas L, Izquierdo C, Clavell J. Circadian rhythm variability in arterial blood pressure. Rev Enferm. 2006;29(6):50-2.
7. Smolensky MH, Lemmer B, Reinberg AE. Chronobiology and chronotherapy of allergic rhinitis and bronchial asthma. Adv Drug Deliv Rev. 2007;59(9-10):852- 82.
8. Harkness JA, Richter MB, Panayi GS, Pette KVD, Unger A, Pownall R, et al. Circadian variation in disease activity in rheumatoid arthritis. BMJ. 1982;284(6315):551-4.
9. Bellamy N, Sothern RB, Campbell J, Buchanan WW. Rhythmic variations in pain, stiffness, and manual dexterity in hand osteoarthritis. Ann Rheum Dis. 2002;61(12):1075-80.
10. Quyyumi AA. Circadian rhythms in cardiovascular disease. Am Heart J. 1990;120(3):726-33.
11. Smolensky MH, Reinberg A, Labrecque G. Twenty-four hour pattern in symptom intensity of viral and allergic rhinitis: treatment implications. J Allergy Clin Immunol. 1995;95(5 Pt 2):1084-96.
12. Mormont MC, Lévi F. Circadian-system alterations during cancer processes: a review. Int J Cancer. 1997;70(2):241-7.
13. Hart FD, Taylor RT, Huskisson EC. Pain at night. Lancet. 1970;1(7652):881-4.
14. Björn L. Circadian rhythms and drug delivery. J Control Release. 1991;16(1-2):63-74.
15. Reinberg A, Smolensky MH. Circadian changes of drug disposition in man. Clin Pharmacokinet. 1982;7(5):401-20.
16. Scott Md AJ, LaDou J. Biological rhythms, shiftwork, and occupational health. In: Bingham E, Cohrssen B, Powell CH, editors. Patty's toxicology. New York: Wiley; 2001.
17. Reinberg A. Recent advances in chronobiology. Acta Med Auxol. 1976;8(2):135-146.
18. Smolensky MH, D'Alonzo GE. Biologic rhythms and medicine. Am J Med. 1988;85(1B):34-46.
19. Reinberg AE. Concepts in chronopharmacology. Annu Rev Pharmacol Toxicol. 1992;32:51-66.
20. Reinberg A. New aspects of human chronopharmacology. Arch Toxicol. 1976;36(3-4):327-39.
21. Ohdo S. Changes in toxicity and effectiveness with timing of drug administration: implications for drug safety. Drug Saf. 2003;26(14):999-1010.
22. Smolensky MH, Hermida RC, Haus E, Portaluppi F, Reinberg A. Biological rhythms, medication safety, and women's health. J Womens Health (Larchmt). 2005;14(1):38-46.
23. Sewlall S, Pillay V, Danckwerts MP, Choonara YE, Ndesendo VM, du Toit LC. A timely review of state-of-the-art chronopharmaceuticals synchronized with biological rhythms. Curr Drug Deliv. 2010;7(5):370-88.
24. Smolensky MH, D'Alonzo GE. Investigative protocols for chronotherapeutics. Basic requirements and illustrative case histories. Ann N Y Acad Sci. 1991;618:465-83.
25. Ohdo S. Chronopharmacology focused on biological clock. Drug Metab Pharmacokinet. 2007;22(1):3-14.
26. Reinberg AE. Concepts of circadian chronopharmacology. Ann N Y Acad Sci. 1991;618:102-15.
27. Bruguerolle B, Philip-joet F, Parrel M, Arnaud A. Unequal twice-daily, sustained-release theophylline dosing in chronic obstructive pulmonary disease. Chronobiol Int. 1987;4(3):381-5.
28. Hassan A, Haefeli WE. Appropriateness of timing of drug administration in electronic prescriptions. Pharm World Sci. 2010;32(2):162-71.
29. Alten R, Doring G, Cutolo M, Gromnica-Ihle E, Witte S, Straub R, et al. Hypothalamus-pituitary-adrenal axis function in patients with rheumatoid arthritis treated with night time-release prednisone. J Rheumatol. 2010;37(10):2025-31.
30. Asmar R, Gosse P, Quere S, Achouba A. Efficacy of morning and evening dosing of amlodipine/valsartan combination in hypertensive patients uncontrolled by 5 mg of amlodipine. Blood Press Monit. 2011;16(2):80-6.
31. Bethke TD, Huennemeyer A, Lahu G, Lemmer B. Chronopharmacology of roflumilast: a comparative pharmacokinetic study of morning versus evening administration in healthy adults. Chronobiol Int. 2010;27(9-10):1843-53.
32. Glass-Marmor L, Paperna T, Galboiz Y, Miller A. Immunomodulation by chronobiologically-based glucocorticoids treatment for multiple sclerosis relapses. J Neuroimmunol. 2009;210(1-2):124-7.
33. Lee RD, Mulford D, Wu J, Atkinson SN. The effect of time-of-day dosing on the pharmacokinetics and pharmacodynamics of dexlansoprazole MR: evidence for dosing flexibility with a dual delayed release proton pump inhibitor. Aliment Pharmacol Ther. 2010;31(9):1001-11.
34. Magnussen H, Verkindre C, Jack D, Jadayel D, Henley M, Woessner R, et al. Indacaterol once-daily is equally effective dosed in the evening or morning in COPD. Respir Med. 2010;104(12):1869-76.
35. Malhotra BK, Crownover PH, LaBadie R, Glue P, MacDiarmid SA. The pharmacokinetic profile of fesoterodine 8 mg with daytime or nighttime dosing. Eur J Clin Pharmacol. 2010;66(2):171-6.
36. Qvortrup C, Jensen BV, Fokstuen T, Nielsen SE, Keldsen N, Glimelius B, et al. A randomized study comparing short-time infusion of oxaliplatin in combination with capecitabine XELOX(30) and chronomodulated XELOX(30) as first-line therapy in patients with advanced colorectal cancer. Ann Oncol. 2010;21(1):87-91.
37. Suic SP, Laus KN, Dosen VM, Ekert M, Mandic Z, Bojic L. Comparison of evening and morning dosing of travoprost 0.004 %/timolol 0.5 % fixed combination in 6 month Period. Coll Antropol. 2010;34(3):847-52.
38. Suzuki K, Aizawa Y. Evaluation of dosing time-related anti-hypertensive efficacy of valsartan in patients with type 2 diabetes. Clin Exp Hypertens. 2011;33(1):56-62.
39. He YL, Valencia J, Zhang Y, Schwartz SL, Ligueros-Saylan M, Foley J, et al. Hormonal and metabolic effects of morning or evening dosing of the dipeptidyl peptidase IV inhibitor vildagliptin in patients with type 2 diabetes. Br J Clin Pharmacol. 2010;70(1):34-42.
40. Warnke A, Schug B, Vanderbist F, Blume H. Significance of the biopharmaceutical properties of tramadol sustained-release formulations for chronopharmacologically optimized treatment of pain from various sources. Int J Clin Pharmacol Ther. 2009;47(6):405-12.
41. Yoon HS, Kim SH, Kim JK, Ko SH, Ko JE, Park SJ, et al. Comparison of effects of morning versus evening administration of ezetimibe/simvastatin on serum cholesterol in patients with primary hypercholesterolemia. Ann Pharmacother. 2011;45(7-8):841-9.
42. Zetterstrom O, Dahl R, Lindqvist A, Olsson P. Comparable morning versus evening administration of once-daily mometasone furoate dry powder inhaler. Respir Med. 2008;102(10):1406-11.
43. Ayala DE, Hermida RC. Sex differences in the administration-time- dependent effects of low-dose aspirin on ambulatory blood pressure in hypertensive subjects. Chronobiol Int. 2010;27(2):345-62.
44. Hermida RC, Ayala DE, Mojon A, Fernandez JR. Ambulatory blood pressure control with bedtime aspirin administration in subjects with prehypertension. Am J Hypertens. 2009;22(8):896-903.
45. Bolk N, Visser TJ, Nijman J, Jongste IJ, Tijssen JGP, Berghout A. Effects of evening vs morning levothyroxine intake: a randomized double-blind crossover trial. Arch Intern Med. 2010;170(22):1996-2003.
46. Hermida RC, Ayala DE, Mojon A, Chayan L, Dominguez MJ, Fontao MJ, et al. Comparison of the effects on ambulatory blood pressure of awakening versus bedtime administration of torasemide in essential hypertension. Chronobiol Int. 2008;25(6):950-70.
47. Hermida RC, Ayala DE. Chronotherapy with the angiotensin-converting enzyme inhibitor ramipril in essential hypertension: improved blood pressure control with bedtime dosing. Hypertension. 2009;54(1):40-6.
48. Hermida RC, Ayala DE, Mojon A, Fernandez JR. Chronotherapy with nifedipine GITS in hypertensive patients: improved efficacy and safety with bedtime dosing. Am J Hypertens. 2008;21(8):948-54.
49. Hermida RC, Ayala DE, Mojon A, Alonso I, Fernandez JR. Reduction of morning blood pressure surge after treatment with nifedipine GITS at bedtime, but not upon awakening, in essential hypertension. Blood Press Monit. 2009;14(4):152-9.
50. Hermida RC, Ayala DE, Chayan L, Mojon A, Fernandez JR. Administration-time-dependent effects of olmesartan on the ambulatory blood pressure of essential hypertension patients. Chronobiol Int. 2009;26(1):61-79.
51. Povedano ST, Garcia De La Villa B. 24-h and nighttime blood pressures in type 2 diabetic hypertensive patients following morning or evening administration of olmesartan. J Clin Hypertens. 2009;11(8):426-31.
52. Hermida RC, Ayala DE, Fontao MJ, Mojon A, Fernandez JR. Chronotherapy with valsartan/amlodipine fixed combination: improved blood pressure control of essential hypertension with bedtime dosing. Chronobiol Int. 2010;27(6):1287-303.
53. Hoshino A, Nakamura T, Matsubara H. The bedtime administration ameliorates blood pressure variability and reduces urinary albumin excretion in amlodipine-olmesartan combination therapy. Clin Exp Hypertens. 2010;32(7):416-22.
54. Meng Y, Zhang Z, Liang X, Wu C, Qi G. Effects of combination therapy with amlodipine and fosinopril administered at different times on blood pressure and circadian blood pressure pattern in patients with essential hypertension. Acta Cardiol. 2010;65(3):309-14.
55. Zeng J, Jia M, Ran H, Tang H, Zhang Y, Zhang J, et al. Fixed-combination of amlodipine and diuretic chronotherapy in the treatment of essential hypertension: improved blood pressure control with bedtime dosing a multicenter, open-label randomized study. Hypertens Res. 2011;34(6):767-72.
56. Konstas AG, Hollo G, Mikropoulos D, Tsironi S, Haidich AB, Embeslidis T, et al. Twenty-four-hour intraocular pressure control with bimatoprost and the bimatoprost/timolol fixed combination administered in the morning, or evening in exfoliative glaucoma. Br J Ophthalmol. 2010;94(2):209-13.
57. Buttgereit F, Doering G, Schaeffler A, Witte S, Sierakowski S, Gromnica-Ihle E, et al. Targeting pathophysiological rhythms: prednisone chronotherapy shows sustained efficacy in rheumatoid arthritis. Ann Rheum Dis. 2010;69(7):1275-80.
58. Takmaz T, Asik S, Kurkcuoglu P, Gurdal C, Can I. Comparison of intraocular pressure lowering effect of once daily morning vs evening dosing of latanoprost/timolol maleate combination. Eur J Ophthalmol. 2008;18(1):60-5.
59. Tharavanij T, Wongtanakarn S, Lerdvuthisopon N, Teeraaunkul S, Youngsriphithak P, Sritipsukho P. Lipid lowering efficacy between morning and evening simvastatin treatment: a randomized double-blind study. J Med Assoc Thail. 2010;93(Suppl 7):S109-13.
60. Okeahialam B, Ohihoin E, Ajuluchukwu J. Chronotherapy in Nigerian hypertensives. Ther Adv Cardiovasc Dis. 2011;5(2):113-8.
61. Almeida L, Loureiro AI, Vaz-Da-Silva M, Torrao L, Maia J, Fernandes-Lopes C, et al. Chronopharmacology of nebicapone, a new catechol-O-methyltransferase inhibitor. Curr Med Res Opin. 2010;26(5):1097-108.
62. Smolensky MH. Compliance to prescription medications entails respect for treatment timing. Chronobiol Int. 2002;19(2):502-5.
63. Smolensky MH, Peppas NA. Chronobiology, drug delivery, and chronotherapeutics. Adv Drug Deliv Rev. 2007;59(9-10):828-51.
64. Kraft M, Martin RJ. Chronobiology and chronotherapy in medicine. Dis Mon. 1995;41(8):501-75.
65. Prins JM, Weverling GJ, van Ketel RJ, Speelman P. Circadian variations in serum levels and the renal toxicity of aminoglycosides in patients. Clin Pharmacol Ther. 1997;62(1):106-11.
66. Ohdo S, Wang DS, Koyanagi S, Takane H, Inoue K, Aramaki H, et al. Basis for dosing time-dependent changes in the antiviral activity of interferon-alpha in mice. J Pharmacol Exp Ther. 2000;294(2):488-93.
67. Lund TM, Torsvik H, Falch D, Christophersen B, Skardal R, Gullestad L. Effect of morning versus evening intake of simvastatin on the serum cholesterol level in patients with coronary artery disease. Am J Cardiol. 2002;90(7):784-6.
68. Qureshi J, Amir M, Ahuja A, Baboota S, Ali J. Chronomodulated drug delivery system of salbutamol sulphate for the treatment of nocturnal asthma. Indian J Pharm Sci. 2008;70(3):351-6.
69. Balan H. Bedtime versus at awakening administration of BP lowering drugs - is it the way to success? Rom J Intern Med. 2009;47(4):355-61.
70. Hermida RC, Ayala DE, Fontao MJ, Mojon A, Alonso I, Fernandez JR. Administration-time-dependent effects of spirapril on ambulatory blood pressure in uncomplicated essential hypertension. Chronobiol Int. 2010;27(3):560-74.
71. Hermida RC, Ayala DE, Mojon A, Fernandez JR. Influence of time of day of blood pressure-lowering treatment on cardiovascular risk in hypertensive patients with type 2 diabetes. Diabetes Care. 2011;34(6):1270-6.
72. Hermida RC, Ayala DE, Fernandez JR, Calvo C. Chronotherapy improves blood pressure control and reverts the nondipper pattern in patients with resistant hypertension. Hypertension. 2008;51(1):69-76.
73. Hermida RC, Ayala DE, Mojon A, Fernandez JR. Effects of time of antihypertensive treatment on ambulatory blood pressure and clinical characteristics of subjects with resistant hypertension. Am J Hypertens. 2010;23(4):432-9.
74. Hermida RC, Ayala DE, Mojon A, Fernandez JR. Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study. Chronobiol Int. 2010;27(8):1629-51.
75. Pizzuto M, Portelli J, Serracino-Inglott A, Zarb-Adami M, Azzopardi LM. Chronopharmacology of antihypertensives. J Appl Ther Res. 2010;7(4):133-40.
76. To H, Yoshimatsu H, Tomonari M, Ida H, Tsurumoto T, Tsuji Y, et al. Methotrexate chronotherapy is effective against rheumatoid arthritis. Chronobiol Int. 2011;28(3):267-74.